Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000039604Phase 4Recruiting
Phase 4, open-label trial of remimazolam and propofol in Not applicable as this is not a disease (4 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Circulatory system change, MOAA/S score and 2 more. Started Nov 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000039604.